AKBA   $0.269  1.41% Market Closed

Akebia Therapeutics Inc
Total Cash 39.50M
totalCashPerShare 0.188
EBITDA 4.08M
Total Debt 104.62M
quickRatio 0.646
currentRatio 1.045
Total Revenue 174.50M
debtToEquity
Revenue/Share 0.88
ROA -0.0884
ROE
grossProfits
freeCashflow 52.90M
operatingCashflow -38.97M
earningsGrowth
revenueGrowth -0.226
grossMargins 0.82293
ebitdaMargins 0.02339
operatingMargins -0.19989
profitMargins -0.23176001
enterpriseValue 456.26M
forwardPE -7.1538463
floatShares 190.38M
sharesOutstanding 210.29M
sharesShort 17.68M
sharesShortPriorMonth 19.06M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.27%
Short Ratio help_outline 14.06%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue -0.161
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -40.44M
trailingEps -0.21%
forwardEps -0.26%
enterpriseToEbitda 111.80
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.06 3Q 2024
institutionsCount 131
lastUpdated Nov. 6, 2024, 5:22 p.m.